What are the major opportunities in the Aurora Kinase B market? What are the strategies for the Aurora Kinase B market?

For detailed insights on the major opportunities and strategies in the Aurora Kinase B market, Read More

How does the Aurora Kinase B market relate to the overall economy and other similar markets?

For detailed insights on Aurora Kinase B's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Aurora Kinase B market growth? SWOT analysis of the Aurora Kinase B market.

For detailed insights on the key dynamics influencing the Aurora Kinase B market growth and SWOT analysis of the Aurora Kinase B industry, Read More

Global Aurora Kinase B Market Report 2025

Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Aurora Kinase B Global Market Report 2025

Name: Aurora Kinase B Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (AZD-2811, CS-2164, Danusertib, Ilorasertib, NMI-900, Other Types), By Application (Anaplastic Large Cell Lymphoma, Kidney Cancer, Lung Cancer, Prostate Cancer, Other Applications), By End-User (Hospitals, Research Institutes, Diagnostic Laboratories, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Aurora Kinase B Market?

Aurora kinase B is a protein enzyme that plays a critical role in cell division, particularly during mitosis. It is involved in regulating chromosome alignment, segregation, and the proper distribution of genetic material to daughter cells. Aurora kinase B is essential for maintaining genomic stability, and its dysregulation is often associated with various cancers.

The main types of aurora kinase B are AZD-2811, CS-2164, danusertib, ilorasertib, NMI-900, and others. AZD-2811 is a nanoparticle formulation of a potent Aurora Kinase B inhibitor designed for the treatment of solid tumors and hematologic malignancies. It is applied for anaplastic large cell lymphoma, kidney cancer, lung cancer, prostate cancer, and others and is used by various end-users such as hospitals, research institutes, diagnostic laboratories, and others.

Aurora Kinase B Market Size and growth rate 2025 to 2029: Graph

What Is The Aurora Kinase B Market Size 2025 And Growth Rate?

The aurora kinase b market size has grown rapidly in recent years. It will grow from $1.14 billion in 2024 to $1.27 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increasing demand for targeted cancer therapies, a rise in the prevalence of cancer globally, increasing investments in precision medicine, growth in the number of clinical trials, and growth in government funding for cancer research.

What Is The Aurora Kinase B Market Growth Forecast?

The aurora kinase b market size is expected to see rapid growth in the next few years. It will grow to $1.99 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to rising investments in innovative cancer treatment, rising incidence of drug-resistant cancers, growing research and development, rising demand for combination therapies, and rising prevalence of solid tumors. Major trends in the forecast period include technological advancements, precision medicine, novel therapies, data analytics, and novel therapies.

Book your 30 minutes free consultation with our research experts

How Is The Aurora Kinase B Market Segmented?

The aurora kinase b market covered in this report is segmented –

1) By Type: AZD-2811, CS-2164, Danusertib, Ilorasertib, NMI-900, Other Types

2) By Application: Anaplastic Large Cell Lymphoma, Kidney Cancer, Lung Cancer, Prostate Cancer, Other Applications

3) By End-User: Hospitals, Research Institutes, Diagnostic Laboratories, Other End-Users

Subsegments:

1) By AZD-2811: Phase I Clinical Trials AZD-2811, Preclinical Development of AZD-2811, AZD-2811 in Combination Therapy, Targeted Cancer Treatment with AZD-2811

2) By CS-2164: Phase II Clinical Trials CS-2164, Preclinical Development of CS-2164, CS-2164 in Targeted Cancer Therapy, CS-2164 Combination Therapy in Clinical Studies

3) By Danusertib: Phase III Clinical Trials Danusertib, Danusertib for Hematological Malignancies, Danusertib for Solid Tumors, Combination Therapy with Danusertib

4) By Ilorasertib: Preclinical Development of Ilorasertib, Ilorasertib in Solid Tumor Treatment, Phase I and II Clinical Trials of Ilorasertib, Ilorasertib in Combination with Chemotherapies

5) By NMI-900: NMI-900 in Early-Stage Clinical Trials, NMI-900 for Targeted Cancer Therapy, Preclinical Studies of NMI-900, NMI-900 Combination Therapy Trials

6) By Other Types: Other Aurora Kinase B Inhibitors in Development, Novel Targeted Aurora Kinase B Drugs, Combination Therapies Involving Aurora Kinase B Inhibitors, Investigational Aurora Kinase B Inhibitors in Oncology

What Is Driving The Aurora Kinase B Market? Rising Cancer Incidence Drives Growth In The Aurora Kinase B Market

The rising incidence of cancer is expected to propel the growth of the aurora kinase B market going forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells that can invade surrounding tissues and metastasize to other parts of the body. Cancer cases are rising due to factors such as an aging population, lifestyle changes, environmental exposures, and improved detection and diagnosis. Aurora kinase B plays a critical role in mitosis, and its overexpression is linked to chromosomal instability and cancer progression. It is often targeted in cancer therapies due to its involvement in tumor cell division. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, an estimated 20 million new cancer cases were reported in 2022, along with 9.7 million deaths. By 2050, new cancer cases are expected to exceed 35 million, representing a 77% increase from 2022. Therefore, the rising incidence of cancer is driving the growth of the aurora kinase B market.

Who Are The Major Players In The Global Aurora Kinase B Market?

Major companies operating in the aurora kinase B market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Amgen Inc., Astellas Pharma Inc., Promega Corporation, Rigel Pharmaceuticals Inc., Tocris Bioscience, BPS Bioscience Inc., Advenchen Laboratories LLC, Shenzhen Chipscreen Biosciences Co. Ltd., Cyclacel Pharmaceuticals Inc., Sareum Holdings plc

What Are The Key Trends Of The Global Aurora Kinase B Market? Innovations In Aurora Kinase B Market

Major companies operating in the aurora kinase B market are developing innovative products, such as aurora kinase inhibitors, to specifically target and disrupt crucial processes in cell division. Aurora kinase inhibitors are drugs designed to block the activity of Aurora kinases, which are critical for cell division, thereby disrupting the proliferation of cancer cells and potentially reducing tumor growth. For instance, in June 2023, Ellipses Pharma, a UK-based biotechnology company, announced the U.S. Food and Drug Administration (FDA) approval for its EP0042, a dual FLT-3 and Aurora kinase inhibitor. EP0042 is being developed as a treatment for acute myeloid leukemia (AML) and acts as an inhibitor targeting both FLT3 and Aurora kinase. This approach is specifically designed for AML patients who have developed resistance to FLT3 inhibitors. Research has demonstrated that dual inhibition of FLT3 and Aurora kinase can overcome acquired resistance to selective FLT3 inhibition both in vitro and in vivo.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Aurora Kinase B Market? Richter Acquires BCI Pharma To Advance Women’s Health Precision Treatments

In June 2024, Gedeon Richter Plc., a Hungary-based pharmaceutical company, acquired BCI Pharma for $13.3 million. This acquisition enhances Richter's ability to develop targeted treatments in this therapeutic area, particularly for conditions such as cancer and endometriosis. BCI Pharma is a Belgium-based manufacturer of aurora kinase B inhibitors.

What Is The Regional Outlook For The Global Aurora Kinase B Market?

North America was the largest region in the aurora kinase B market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aurora kinase b market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the aurora kinase B market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Aurora Kinase B Market?

The aurora kinase B market consists of sales of aurora kinase B inhibitors, antibodies, diagnostic kits, assay kits, and recombinant proteins. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Aurora Kinase B Industry?

The aurora kinase B market research report is one of a series of new reports from The Business Research Company that provides aurora kinase B market statistics, including aurora kinase B industry global market size, regional shares, competitors with a aurora kinase B market share, detailed aurora kinase B market segments, market trends and opportunities, and any further data you may need to thrive in the aurora kinase B industry. This aurora kinase B market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Author : Abhilash Pyata

Aurora Kinase B Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	1.27 billion
Revenue Forecast In 2034	$1.99 billion
Growth Rate	CAGR of 11.8% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The aurora kinase b market covered in this report is segmented – 1) By Type: AZD-2811, CS-2164, Danusertib, Ilorasertib, NMI-900, Other Types 2) By Application: Anaplastic Large Cell Lymphoma, Kidney Cancer, Lung Cancer, Prostate Cancer, Other Applications 3) By End-User: Hospitals, Research Institutes, Diagnostic Laboratories, Other End-Users Subsegments: 1) By AZD-2811: Phase I Clinical Trials AZD-2811, Preclinical Development of AZD-2811, AZD-2811 in Combination Therapy, Targeted Cancer Treatment with AZD-2811 2) By CS-2164: Phase II Clinical Trials CS-2164, Preclinical Development of CS-2164, CS-2164 in Targeted Cancer Therapy, CS-2164 Combination Therapy in Clinical Studies 3) By Danusertib: Phase III Clinical Trials Danusertib, Danusertib for Hematological Malignancies, Danusertib for Solid Tumors, Combination Therapy with Danusertib 4) By Ilorasertib: Preclinical Development of Ilorasertib, Ilorasertib in Solid Tumor Treatment, Phase I and II Clinical Trials of Ilorasertib, Ilorasertib in Combination with Chemotherapies 5) By NMI-900: NMI-900 in Early-Stage Clinical Trials, NMI-900 for Targeted Cancer Therapy, Preclinical Studies of NMI-900, NMI-900 Combination Therapy Trials 6) By Other Types: Other Aurora Kinase B Inhibitors in Development, Novel Targeted Aurora Kinase B Drugs, Combination Therapies Involving Aurora Kinase B Inhibitors, Investigational Aurora Kinase B Inhibitors in Oncology
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Amgen Inc., Astellas Pharma Inc., Promega Corporation, Rigel Pharmaceuticals Inc., Tocris Bioscience, BPS Bioscience Inc., Advenchen Laboratories LLC, Shenzhen Chipscreen Biosciences Co. Ltd., Cyclacel Pharmaceuticals Inc., Sareum Holdings plc
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Aurora Kinase B Market Characteristics

3. Aurora Kinase B Market Trends And Strategies

4. Aurora Kinase B Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Aurora Kinase B Growth Analysis And Strategic Analysis Framework

5.1. Global Aurora Kinase B PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Aurora Kinase B Market Growth Rate Analysis

5.4. Global Aurora Kinase B Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Aurora Kinase B Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Aurora Kinase B Total Addressable Market (TAM)

6. Aurora Kinase B Market Segmentation

6.1. Global Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

AZD-2811

CS-2164

Danusertib

Ilorasertib

NMI-900

Other Types

6.2. Global Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Anaplastic Large Cell Lymphoma

Kidney Cancer

Lung Cancer

Prostate Cancer

Other Applications

6.3. Global Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Research Institutes

Diagnostic Laboratories

Other End-Users

6.4. Global Aurora Kinase B Market, Sub-Segmentation Of AZD-2811, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Phase I Clinical Trials AZD-2811

Preclinical Development of AZD-2811

AZD-2811 in Combination Therapy

Targeted Cancer Treatment with AZD-2811

6.5. Global Aurora Kinase B Market, Sub-Segmentation Of CS-2164, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Phase II Clinical Trials CS-2164

Preclinical Development of CS-2164

CS-2164 in Targeted Cancer Therapy

CS-2164 Combination Therapy in Clinical Studies

6.6. Global Aurora Kinase B Market, Sub-Segmentation Of Danusertib, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Phase III Clinical Trials Danusertib

Danusertib for Hematological Malignancies

Danusertib for Solid Tumors

Combination Therapy with Danusertib

6.7. Global Aurora Kinase B Market, Sub-Segmentation Of Ilorasertib, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Preclinical Development of Ilorasertib

Ilorasertib in Solid Tumor Treatment

Phase I and II Clinical Trials of Ilorasertib

Ilorasertib in Combination with Chemotherapies

6.8. Global Aurora Kinase B Market, Sub-Segmentation Of NMI-900, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

NMI-900 in Early-Stage Clinical Trials

NMI-900 for Targeted Cancer Therapy

Preclinical Studies of NMI-900

NMI-900 Combination Therapy Trials

6.9. Global Aurora Kinase B Market, Sub-Segmentation Of Other Aurora Kinase B Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Other Aurora Kinase B Inhibitors in Development

Novel Targeted Aurora Kinase B Drugs

Combination Therapies Involving Aurora Kinase B Inhibitors

Investigational Aurora Kinase B Inhibitors in Oncology

7. Aurora Kinase B Market Regional And Country Analysis

7.1. Global Aurora Kinase B Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Aurora Kinase B Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Aurora Kinase B Market

8.1. Asia-Pacific Aurora Kinase B Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Aurora Kinase B Market

9.1. China Aurora Kinase B Market Overview

9.2. China Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Aurora Kinase B Market

10.1. India Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Aurora Kinase B Market

11.1. Japan Aurora Kinase B Market Overview

11.2. Japan Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Aurora Kinase B Market

12.1. Australia Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Aurora Kinase B Market

13.1. Indonesia Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Aurora Kinase B Market

14.1. South Korea Aurora Kinase B Market Overview

14.2. South Korea Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Aurora Kinase B Market

15.1. Western Europe Aurora Kinase B Market Overview

15.2. Western Europe Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Aurora Kinase B Market

16.1. UK Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Aurora Kinase B Market

17.1. Germany Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Aurora Kinase B Market

18.1. France Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Aurora Kinase B Market

19.1. Italy Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Aurora Kinase B Market

20.1. Spain Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Aurora Kinase B Market

21.1. Eastern Europe Aurora Kinase B Market Overview

21.2. Eastern Europe Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Aurora Kinase B Market

22.1. Russia Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Aurora Kinase B Market

23.1. North America Aurora Kinase B Market Overview

23.2. North America Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Aurora Kinase B Market

24.1. USA Aurora Kinase B Market Overview

24.2. USA Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Aurora Kinase B Market

25.1. Canada Aurora Kinase B Market Overview

25.2. Canada Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Aurora Kinase B Market

26.1. South America Aurora Kinase B Market Overview

26.2. South America Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Aurora Kinase B Market

27.1. Brazil Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Aurora Kinase B Market

28.1. Middle East Aurora Kinase B Market Overview

28.2. Middle East Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Aurora Kinase B Market

29.1. Africa Aurora Kinase B Market Overview

29.2. Africa Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Aurora Kinase B Market Competitive Landscape And Company Profiles

30.1. Aurora Kinase B Market Competitive Landscape

30.2. Aurora Kinase B Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Aurora Kinase B Market Other Major And Innovative Companies

31.1. Sanofi SA

31.2. Bristol-Myers Squibb Company

31.3. AstraZeneca PLC

31.4. Novartis AG

31.5. GlaxoSmithKline plc

31.6. Takeda Pharmaceutical Company Limited

31.7. Boehringer Ingelheim International GmbH

31.8. Amgen Inc.

31.9. Astellas Pharma Inc.

31.10. Promega Corporation

31.11. Rigel Pharmaceuticals Inc.

31.12. Tocris Bioscience

31.13. BPS Bioscience Inc.

31.14. Advenchen Laboratories LLC

31.15. Shenzhen Chipscreen Biosciences Co. Ltd.

32. Global Aurora Kinase B Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Aurora Kinase B Market

34. Recent Developments In The Aurora Kinase B Market

35. Aurora Kinase B Market High Potential Countries, Segments and Strategies

35.1 Aurora Kinase B Market In 2029 - Countries Offering Most New Opportunities

35.2 Aurora Kinase B Market In 2029 - Segments Offering Most New Opportunities

35.3 Aurora Kinase B Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Aurora Kinase B Market, Sub-Segmentation Of AZD-2811, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Aurora Kinase B Market, Sub-Segmentation Of CS-2164, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Aurora Kinase B Market, Sub-Segmentation Of Danusertib, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Aurora Kinase B Market, Sub-Segmentation Of Ilorasertib, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Aurora Kinase B Market, Sub-Segmentation Of NMI-900, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Aurora Kinase B Market, Sub-Segmentation Of Other Aurora Kinase B Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Aurora Kinase B Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Aurora Kinase B Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Pfizer Inc. Financial Performance

Table 81: Johnson & Johnson Financial Performance

Table 82: Roche Holding AG Financial Performance

Table 83: Merck & Co. Inc. Financial Performance

Table 84: AbbVie Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Aurora Kinase B Market, Sub-Segmentation Of AZD-2811, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Aurora Kinase B Market, Sub-Segmentation Of CS-2164, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Aurora Kinase B Market, Sub-Segmentation Of Danusertib, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Aurora Kinase B Market, Sub-Segmentation Of Ilorasertib, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Aurora Kinase B Market, Sub-Segmentation Of NMI-900, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Aurora Kinase B Market, Sub-Segmentation Of Other Aurora Kinase B Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Aurora Kinase B Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Aurora Kinase B Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Pfizer Inc. Financial Performance

Figure 81: Johnson & Johnson Financial Performance

Figure 82: Roche Holding AG Financial Performance

Figure 83: Merck & Co. Inc. Financial Performance

Figure 84: AbbVie Inc. Financial Performance

Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

$8.21 Billion Forecast for Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market by 2029, Backed by Demand and Innovation

Fentanyl Market Forecast Reaching $22.03 Billion by 2029 at 6.5% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Skin Cancer Drugs Global Market Report 2025 – By Type (Actinic Keratoses (AK), Basal cell carcinoma (BCC), Squamous cell carcinoma (SCC), Melanoma), By Drug Class (Chemotherapy, Immunotherapy, Targeted Agents & Other Dru...

Pancreatic Cancer Drugs Global Market Report 2025 – By Type (Pancreatic Neuroendocrine Cancer Drugs, Pancreatic Exocrine Cancer Drugs), By Drug Combination (Single, Double, Triplet, Quadruplet), By End User (Hospital Pha...

Breast Cancer Drugs Global Market Report 2025 – By Type (Metastatic Breast Cancer, Triple Negative Breast Cancer, Others (Ductal Carcinoma Insitu, Invasive Ductal Carcinoma, Inflammatory Breast Cancer, Breast Cancer Duri...

Lung Cancer Drugs Global Market Report 2025 – By Drugs (Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs), By Disease Type (Small cell lung cancer (SCLC), Non-small cell lung cancer (NSCLC))...

Cancer Diagnostics Global Market Report 2025 – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast Cancer, Li...

Bladder Cancer Drugs Global Market Report 2025 – By Type (Non-Muscle-Invasive Bladder Cancer, Muscle-Invasive Bladder Cancer), By Application (Low-Grade Tumors, High-Grade Tumors), By Distribution Channel (Hospital Pharm...

Blood Cancer Drugs Global Market Report 2025 – By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan/Mabthera (Rituximab), Gleevec/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotin...

Frequently Asked Questions

What is the definition of the Aurora Kinase B market?

How will the Aurora Kinase B market drivers and restraints affect the market dynamics? What forces will shape the Aurora Kinase B industry going forward?

The Aurora Kinase B market major growth driver - Rising Cancer Incidence Drives Growth In The Aurora Kinase B Market. For further insights on the Aurora Kinase B market, request a sample here

What is the forecast market size or the forecast market value of the Aurora Kinase B market?

The Aurora Kinase B market size has grown strongly in recent years. The aurora kinase b market size has grown rapidly in recent years. It will grow from $1.14 billion in 2024 to $1.27 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increasing demand for targeted cancer therapies, a rise in the prevalence of cancer globally, increasing investments in precision medicine, growth in the number of clinical trials, and growth in government funding for cancer research. The aurora kinase b market size is expected to see rapid growth in the next few years. It will grow to $1.99 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to rising investments in innovative cancer treatment, rising incidence of drug-resistant cancers, growing research and development, rising demand for combination therapies, and rising prevalence of solid tumors. Major trends in the forecast period include technological advancements, precision medicine, novel therapies, data analytics, and novel therapies. For further insights on the Aurora Kinase B market, request a sample here

How is the Aurora Kinase B market segmented?

The aurora kinase b market covered in this report is segmented –
1) By Type: AZD-2811, CS-2164, Danusertib, Ilorasertib, NMI-900, Other Types
2) By Application: Anaplastic Large Cell Lymphoma, Kidney Cancer, Lung Cancer, Prostate Cancer, Other Applications
3) By End-User: Hospitals, Research Institutes, Diagnostic Laboratories, Other End-Users Subsegments:
1) By AZD-2811: Phase I Clinical Trials AZD-2811, Preclinical Development of AZD-2811, AZD-2811 in Combination Therapy, Targeted Cancer Treatment with AZD-2811
2) By CS-2164: Phase II Clinical Trials CS-2164, Preclinical Development of CS-2164, CS-2164 in Targeted Cancer Therapy, CS-2164 Combination Therapy in Clinical Studies
3) By Danusertib: Phase III Clinical Trials Danusertib, Danusertib for Hematological Malignancies, Danusertib for Solid Tumors, Combination Therapy with Danusertib
4) By Ilorasertib: Preclinical Development of Ilorasertib, Ilorasertib in Solid Tumor Treatment, Phase I and II Clinical Trials of Ilorasertib, Ilorasertib in Combination with Chemotherapies
5) By NMI-900: NMI-900 in Early-Stage Clinical Trials, NMI-900 for Targeted Cancer Therapy, Preclinical Studies of NMI-900, NMI-900 Combination Therapy Trials
6) By Other Types: Other Aurora Kinase B Inhibitors in Development, Novel Targeted Aurora Kinase B Drugs, Combination Therapies Involving Aurora Kinase B Inhibitors, Investigational Aurora Kinase B Inhibitors in Oncology For further insights on the Aurora Kinase B market, request a sample here

Which region has the largest share of the Aurora Kinase B market? What are the other regions covered in the report?

Who are the major players in the Aurora Kinase B market?

What are the key trends in the Aurora Kinase B market?

Major trends in the Aurora Kinase B market include Innovations In Aurora Kinase B Market. For further insights on the Aurora Kinase B market, request a sample here.